[350 Pages Report] Newly released data from the fertility supplements market analyzed by FMI estimates that the fertility supplements market enjoyed year-on-year (YoY) growth of 8.3% in 2021 to total 243,820 MT. The fertility supplements market is expected to witness a prominent growth rate of a CAGR of 8.3% to reach the value of US$ 4,382 Mn in 2031.
| Attribute | Details |
|---|---|
| Market Size Value in 2020 | US$ 1,817.6 Million |
| Market Forecast Value in 2031 | US$ 4,382 Million |
| Global Growth Rate | ~8.3% |
| Forecast Period | 2021 to 2031 |
Fertility supplements have been found to aid in increasing fertility rates, healthy pregnancy, and boosting delivery by promoting ovulation and improving hormonal profiles. Men and women of childbearing age can both experience infertility to avoid which, consumers are taking preventative healthcare measures like fertility supplements, therefore, boosting the market.
According to research by the American Society for Reproductive Medicine, the male partner is responsible for infertility in roughly 40% of infertile couples, and approximately 80%–90% of these couples are treated with pharmaceuticals including fertility supplements products like herbal fertility supplements, natural fertility supplements, vegan fertility supplements, etc. As a result, boosting the fertility supplements market.
Fertility supplements business research performed by FMI covers crucial findings such as the latest developments by key producers and projected production capacity, the current pricing of various levels of the supply chain, and price optimization plan across the value chain, as well as an economic evaluation of fertility supplements manufacturing.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Market Statistics | Details |
|---|---|
| H1,2021 (A) | 8.2% |
| H1,2022 Projected (P) | 8.3% |
| H1,2022 Outlook (O) | 9.1% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 83 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 91.3 ↑ |
FMI provides an evaluation and comparison of the market growth rates and future development possibilities on a half-yearly basis for the global market. Under the subjective influence of macro and industry factors, some demographic and innovation factors have a significant influence on the market.
There have been a number of recent changes in this market, including:
The Fertility Supplements Market has grown by 8.2% globally in the first half of 2021. However, this growth is not uniformly distributed across all geographical areas, with the developing markets registering greater growth rates of 9.1%. Thus, there will be a 91.3 BPS point difference between the predicted and projected growth in H1 2022.
The primary causes of this variation in growth rate are ascribed to the market's slow or rapid uptake during the first half of the projected period as a result of improving end-user demand in important economies and their expanding populations.
China and India in particular are both experiencing a growth in their consumption patterns, which is driving up demand for Fertility Supplements Market. Numerous other market segments should also perform well and have bright development potential in the second half of the projected period.
Despite these promising developments, the business is still expected to face significant obstacles, such as shifting customer preferences, strict trade restrictions, and a lack of security in the supply of raw materials and other manufacturing inputs.
As per FMI – market study and competitive intellect provider, in past few years, the inclusive market value for fertility supplements grew at a compound annual growth rate of around 6.4% in 2021.
Market participants are striving to strategically develop distribution warehouses for fertility supplements in order to support time- and cost-effective logistic operations. Rising infertility rates worldwide are another key factor for the rising demand for fertility supplements. 10% of women are facing infertility issues worldwide, according to WHO. The concern for the issue has caused a rise in the demand for the product.
According to FMI, the US fertility supplements market is expected to grow at a CAGR of 8.9% by 2031 due to the fact that today's lifestyle causes more harm to the average person than ever before. According to the American Society for Reproductive Medicine, many men and women of reproductive age in the United States smoke cigarettes. Cigarette smoking has a negative impact on a person's general health and well-being. It also has a negative impact on their fertility. The fertility supplements market is expected to grow as more people become aware of the current problem and learn about potential remedies.
Germany has a market share of 20.9% in the European fertility supplements market, in 2021 (According to FMI) with a growth rate of 8.6% over the assessment period.
In Germany, the rising frequency of obesity and the expanding number of diabetic patients are driving up demand for fertility supplements. Menstrual disorders and anovulation are more common in overweight women. Women who are overweight or obese are at a higher risk of having a miscarriage.
These women have a higher risk of sub fecundity and infertility, as well as higher risks of conception, miscarriage, and pregnancy problems, therefore, the country has a higher consumption of the product as a preventative measure.
India has a market share of 42.1% in the South Asian fertility supplements market, in 2021 (According to FMI) with a growth rate of 10.9% over the assessment period.
Infertility has been one of the most common health difficulties that many young couples have been dealing with in recent years in the country. Sedentary lives with little physical activity, growing stress levels, and unpredictable sleep patterns are only a few of the factors that contribute to infertility, pushing some to resort to in vitro fertilization. Infertility affects between 10% to 14% of the Indian population, according to The Indian Society of Assisted Reproduction, with greater rates in metropolitan areas, where one out of every six couples is affected.
According to the most recent assessment by FMI, the fertility supplements market size of Brazil in 2021 is US$ 77.0 Mn and is expected to expand at a CAGR of 7.1% by 2031.
Preterm birth has been on the rise all throughout the world, especially in Brazil. Because of the greater rates of morbidity and mortality, as well as the long-term health consequences of preterm birth, posing a substantial public health threat. This augments the sales of fertility supplements in the Brazilian market as a preventative measure.
According to FMI, the sales of fertility supplements in China are assessed at around 51.6% of the overall East Asian market in 2021, with a growth rate of 7.6%.
The growth has been recorded due to the rising awareness of the benefits provided by fertility supplements for to be mothers. The heightening knowledge about, supplementing may also be beneficial when attempting to conceive, which is also boosting the market in the country.
Principal Consultant
The natural fertility supplements segment of the market holds a significant percentage, which is expected to rise at a CAGR of 9.0% by 2031.
In 2021, the natural segment of the fertility supplements market accounted for US$ 1,057.3 Mn and is expected to expand at a market share of 56.7% by 2031 due to the introduction of innovative products and technical advances like nutrition trackers, fitness trackers, etc., in the health and wellness industry. In the near future, increasing the use of plant-derived products for a healthy lifestyle and lowering the risk of side effects is predicted to drive demand even higher.
According to FMI, the women population is anticipated to witness a significant consumption of fertility supplements and experience a lucrative growth rate of CAGR 8.2% over the forecast period.
Immune system factors, varicocele, hypogonadism, systemic disease, urogenital infection, sexual factors, are some of the prominent factors leading to fertility problems in women, therefore, promoting the fertility supplements market amongst this end user category.
The capsules category accounted for a significant market share of 43.5% in the fertility supplements industry in 2021. These solutions allow for innovative ingredient combinations, give protection from sensitive ingredients, prevent gastrointestinal irritation, and assure the delivery of oil and fat-soluble nutrients. This element is expected to contribute to the boost of the capsule fertility supplements market.
The players are expanding in number due to the rising demand for fertility supplements in various parts of the world. The companies are working on research and development to understand the market in-depth and innovate the product to match the competition like organic, non-GMO, etc.
A prenatal nutrition and education company, needed, has raised $5.8 million through seed funding to expand its products offerings to include sleep, stress, and reproductive difficulties. The money will also be used to fund new clinical studies on nutrition during pregnancy by the Los Angeles-based company, therefore, promoting the fertility supplements market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Market Size Value in 2020 | US$ 1,817.6 Million |
| Market Forecast Value in 2031 | US$ 4,382 Million |
| Global Growth Rate | ~8.3% |
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | MT for Volume and US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe East Asia, South Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Rest of Latin America, Germany, Italy, France, UK, Spain, BENELUX, Nordic, Russia, Poland, Rest of Europe, India, Thailand, Indonesia, Malaysia, Singapore, Rest of South Asia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa, Rest of MEA |
| Key Market Segments Covered | Type, Form, End User, Sales Channel, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
By Type :
By Form :
By End User :
By Sales Channel :
Region :
The fertility supplements market size is worth more than US$ 1,968.4 Mn in 2021.
Fertility supplements consumption is expected to grow at a CAGR of around 8.3% during the period 2021-2031.
In terms of revenue fertility supplements grew at a CAGR of around 6.4% during 2016-2020
Fertility supplements are gaining traction as a preventative health care measure against rising infertility rates, and advanced technologies, are the latest trends of fertility supplements being observed in the market.
Market companies are choosing to aim at research and development, consolidation of distribution channels in emerging countries, new product introductions to stay a noticeable player in the global market.
The top 20 producers of fertility supplements hold around 45-50% of the market share.
The US, Australia, GCC Countries, China, and Germany are the major countries driving demand for fertility supplements.
Europe holds around 25.6% of the total fertility supplements revenue share in 2021.
The US fertility supplements market is projected to grow at a CAGR of around 8.9% over the next ten years.
The report presents a detailed cost analysis of fertility supplements based on form i.e. natural, synthetic, and blend.
1. Market Overview
1.1. Market Coverage / Taxonomy
1.2. Market Definition / Scope / Limitations
2. The Massive Impact of the Crisis
2.1. Global Market Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2025) and Long Term (2026-2031)
2.1.1. Optimistic Scenario
2.1.1.1. China
2.1.1.2. US
2.1.1.3. India
2.1.1.4. Euro Zone
2.1.1.5. Asia Pacific
2.1.1.6. Rest of the World
2.1.2. Likely Scenario
2.1.2.1. China
2.1.2.2. US
2.1.2.3. India
2.1.2.4. Euro Zone
2.1.2.5. Asia Pacific
2.1.2.6. Rest of the World
2.1.3. Pessimistic Scenario
2.1.3.1. China
2.1.3.2. US
2.1.3.3. India
2.1.3.4. Euro Zone
2.1.3.5. Asia Pacific
2.1.3.6. Rest of the World
2.2. Key Factors Impacting the Market
Note: Market Assessment shall be Provided for Likely Scenario
3. Market Background
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Type Launches
3.6. Type Claims & Nutritional Information Scan by Buyers
3.7. Scan by Buyers
3.8. Macro-Economic Factors
3.9. Forecast Factors - Relevance & Impact
3.10. Consumers Survey Analysis
4. Key Regulations
4.1. Packaging & Labelling Regulations
4.2. Certifications and Certifying Agency Overview
4.3. Import/Export Policies
5. Value Chain Analysis
5.1. Operating margins at each node of the supply chain
5.2. List of Active Market Participants
5.2.1. Raw Material Suppliers
5.2.2. Type Manufacturers
5.2.3. Key Brands
6. Production and Trade Outlook-Fertility Supplements
6.1. Total Production Vs Consumption by Country
6.2. Key Importing Countries by Volume/Value
6.3. Key Exporting Countries by Volume/Value
6.4. Natural Market Overview
6.4.1. Global Natural Supplements Production Overview
6.4.2. Countries with largest Natural Supplements Consumption
6.5. Per Capita Consumption Analysis
6.5.1. Per Capita Consumption Analysis By Country
6.5.2. Per Capita Expenditure on Fertility Supplements
7. Global Market Demand Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020
7.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031
7.3. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis (US$/Metric Tons) By Form
8.2. Pricing Break-up By category
8.3. Global Average Pricing Analysis Benchmark
9. Global Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Type, 2016 - 2020
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Type, 2021-2031
10.3.1. Capsules
10.3.2. Soft gels
10.3.3. Powders
10.3.4. Liquids
10.3.5. Others
10.4. Market Attractiveness Analysis By Type
11. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Form
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Form, 2016 - 2020
11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Form, 2021-2031
11.3.1. Natural
11.3.2. Synthetic
11.3.3. Blend
11.4. Market Attractiveness Analysis By Form
12. Global Market Analysis 2016-2020 and Forecast 2021-2031, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2016 - 2020
12.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User, 2021-2031
12.3.1. Men
12.3.2. Women
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Sales Channel
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2016 - 2020
13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2021-2031
13.3.1. Over the Counter
13.3.2. Prescribed
13.4. Market Attractiveness Analysis By Sales Channel
14. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016 - 2020
14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
15.4.1. By Country
15.4.1.1. U.S.
15.4.1.2. Canada
15.4.2. By Type
15.4.3. By Form
15.4.4. End User
15.4.5. Sales Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Type
15.5.3. By Form
15.5.4. End User
15.5.5. Sales Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Latin America Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
16.4.1. By Country
16.4.1.1. Brazil
16.4.1.2. Mexico
16.4.1.3. Argentina
16.4.1.4. Chile
16.4.1.5. Rest of Latin America
16.4.2. By Type
16.4.3. By Form
16.4.4. End User
16.4.5. Sales Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Type
16.5.3. By Form
16.5.4. End User
16.5.5. Sales Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Europe Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
17.4.1. By Country
17.4.1.1. EU-4
17.4.1.2. U.K.
17.4.1.3. BENELUX
17.4.1.4. Nordic
17.4.1.5. Russia
17.4.1.6. Poland
17.4.1.7. Rest of Europe
17.4.2. By Type
17.4.3. By Form
17.4.4. End User
17.4.5. Sales Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Type
17.5.3. By Form
17.5.4. End User
17.5.5. Sales Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Type
18.4.3. By Form
18.4.4. End User
18.4.5. Sales Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Type
18.5.3. By Form
18.5.4. End User
18.5.5. Sales Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. South Asia Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
19.4.1. By Country
19.4.1.1. India
19.4.1.2. Thailand
19.4.1.3. Singapore
19.4.1.4. Malaysia
19.4.1.5. Rest of South Asia
19.4.2. By Type
19.4.3. By Form
19.4.4. End User
19.4.5. Sales Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Type
19.5.3. By Form
19.5.4. End User
19.5.5. Sales Channel
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Oceania Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
20.4.1. By Country
20.4.1.1. Australia
20.4.1.2. New Zealand
20.4.2. By Type
20.4.3. By Form
20.4.4. End User
20.4.5. Sales Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Type
20.5.3. By Form
20.5.4. End User
20.5.5. Sales Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2031
21.1. Introduction
21.2. Pricing Analysis
21.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020
21.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031
21.4.1. By Country
21.4.1.1. GCC Countries
21.4.1.2. Turkey
21.4.1.3. Northern Africa
21.4.1.4. South Africa
21.4.1.5. Rest of Middle East and Africa
21.4.2. By Type
21.4.3. By Form
21.4.4. End User
21.4.5. Sales Channel
21.5. Market Attractiveness Analysis
21.5.1. By Country
21.5.2. By Type
21.5.3. By Form
21.5.4. End User
21.5.5. Sales Channel
21.6. Market Trends
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
22. Key Countries Bulk Ingredients Market Analysis 2016–2020 and Forecast 2021–2031
22.1. U.S.
22.1.1. Introduction
22.1.2. Pricing Analysis (2016, 2021, 2031)
22.1.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.1.3.1. By Type
22.1.3.2. By Form
22.1.3.3. By End User
22.1.3.4. By Sales Channel
22.2. Canada
22.2.1. Introduction
22.2.2. Pricing Analysis (2016, 2021, 2031)
22.2.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.2.3.1. By Type
22.2.3.2. By Form
22.2.3.3. By End User
22.2.3.4. By Sales Channel
22.3. Brazil
22.3.1. Introduction
22.3.2. Pricing Analysis (2016, 2021, 2031)
22.3.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.3.3.1. By Type
22.3.3.2. By Form
22.3.3.3. By End User
22.3.3.4. By Sales Channel
22.4. Mexico
22.4.1. Introduction
22.4.2. Pricing Analysis (2016, 2021, 2031)
22.4.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.4.3.1. By Type
22.4.3.2. By Form
22.4.3.3. By End User
22.4.3.4. By Sales Channel
22.5. Argentina
22.5.1. Introduction
22.5.2. Pricing Analysis (2016, 2021, 2031)
22.5.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.5.3.1. By Type
22.5.3.2. By Form
22.5.3.3. By End User
22.5.3.4. By Sales Channel
22.6. Peru
22.6.1. Introduction
22.6.2. Pricing Analysis (2016, 2021, 2031)
22.6.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.6.3.1. By Type
22.6.3.2. By Form
22.6.3.3. By End User
22.6.3.4. By Sales Channel
22.7. Chile
22.7.1. Introduction
22.7.2. Pricing Analysis (2016, 2021, 2031)
22.7.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.7.3.1. By Type
22.7.3.2. By Form
22.7.3.3. By End User
22.7.3.4. By Sales Channel
22.8. Germany
22.8.1. Introduction
22.8.2. Pricing Analysis (2016, 2021, 2031)
22.8.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.8.3.1. By Type
22.8.3.2. By Form
22.8.3.3. By End User
22.8.3.4. By Sales Channel
22.9. Italy
22.9.1. Introduction
22.9.2. Pricing Analysis (2016, 2021, 2031)
22.9.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.9.3.1. By Type
22.9.3.2. By Form
22.9.3.3. By End User
22.9.3.4. By Sales Channel
22.10. France
22.10.1. Introduction
22.10.2. Pricing Analysis (2016, 2021, 2031)
22.10.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.10.3.1. By Type
22.10.3.2. By Form
22.10.3.3. By End User
22.10.3.4. By Sales Channel
22.11. U.K.
22.11.1. Introduction
22.11.2. Pricing Analysis (2016, 2021, 2031)
22.11.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.11.3.1. By Type
22.11.3.2. By Form
22.11.3.3. By End User
22.11.3.4. By Sales Channel
22.12. Spain
22.12.1. Introduction
22.12.2. Pricing Analysis (2016, 2021, 2031)
22.12.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.12.3.1. By Type
22.12.3.2. By Form
22.12.3.3. By End User
22.12.3.4. By Sales Channel
22.13. BENELUX
22.13.1. Introduction
22.13.2. Pricing Analysis (2016, 2021, 2031)
22.13.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.13.3.1. By Type
22.13.3.2. By Form
22.13.3.3. By End User
22.13.3.4. By Sales Channel
22.14. Russia
22.14.1. Introduction
22.14.2. Pricing Analysis (2016, 2021, 2031)
22.14.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.14.3.1. By Type
22.14.3.2. By Form
22.14.3.3. By End User
22.14.3.4. By Sales Channel
22.15. India
22.15.1. Introduction
22.15.2. Pricing Analysis (2016, 2021, 2031)
22.15.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.15.3.1. By Type
22.15.3.2. By Form
22.15.3.3. By End User
22.15.3.4. By Sales Channel
22.16. Thailand
22.16.1. Introduction
22.16.2. Pricing Analysis (2016, 2021, 2031)
22.16.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.16.3.1. By Type
22.16.3.2. By Form
22.16.3.3. By End User
22.16.3.4. By Sales Channel
22.17. Indonesia
22.17.1. Introduction
22.17.2. Pricing Analysis (2016, 2021, 2031)
22.17.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.17.3.1. By Type
22.17.3.2. By Form
22.17.3.3. By End User
22.17.3.4. By Sales Channel
22.18. Malaysia
22.18.1. Introduction
22.18.2. Pricing Analysis (2016, 2021, 2031)
22.18.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.18.3.1. By Type
22.18.3.2. By Form
22.18.3.3. By End User
22.18.3.4. By Sales Channel
22.19. China
22.19.1. Introduction
22.19.2. Pricing Analysis (2016, 2021, 2031)
22.19.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.19.3.1. By Type
22.19.3.2. By Form
22.19.3.3. By End User
22.19.3.4. By Sales Channel
22.20. Japan
22.20.1. Introduction
22.20.2. Pricing Analysis (2016, 2021, 2031)
22.20.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.20.3.1. By Type
22.20.3.2. By Form
22.20.3.3. By End User
22.20.3.4. By Sales Channel
22.21. South Korea
22.21.1. Introduction
22.21.2. Pricing Analysis (2016, 2021, 2031)
22.21.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.21.3.1. By Type
22.21.3.2. By Form
22.21.3.3. By End User
22.21.3.4. By Sales Channel
22.22. Australia
22.22.1. Introduction
22.22.2. Pricing Analysis (2016, 2021, 2031)
22.22.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.22.3.1. By Type
22.22.3.2. By Form
22.22.3.3. By End User
22.22.3.4. By Sales Channel
22.23. New Zealand
22.23.1. Introduction
22.23.2. Pricing Analysis (2016, 2021, 2031)
22.23.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.23.3.1. By Type
22.23.3.2. By Form
22.23.3.3. By End User
22.23.3.4. By Sales Channel
22.24. GCC Countries
22.24.1. Introduction
22.24.2. Pricing Analysis (2016, 2021, 2031)
22.24.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.24.3.1. By Type
22.24.3.2. By Form
22.24.3.3. By End User
22.24.3.4. By Sales Channel
22.25. Central Africa
22.25.1. Introduction
22.25.2. Pricing Analysis (2016, 2021, 2031)
22.25.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.25.3.1. By Type
22.25.3.2. By Form
22.25.3.3. By End User
22.25.3.4. By Sales Channel
22.26. North Africa
22.26.1. Introduction
22.26.2. Pricing Analysis (2016, 2021, 2031)
22.26.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.26.3.1. By Type
22.26.3.2. By Form
22.26.3.3. By End User
22.26.3.4. By Sales Channel
22.27. South Africa
22.27.1. Introduction
22.27.2. Pricing Analysis (2016, 2021, 2031)
22.27.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031
22.27.3.1. By Type
22.27.3.2. By Form
22.27.3.3. By End User
22.27.3.4. By Sales Channel
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Company Share Analysis of Top Players
23.2.1. Company share by Region
23.2.2. Company Share By Type
23.3. Market Presence Analysis
23.3.1. By Regional footprint of Players
23.3.2. Product foot print by Players
23.3.3. Channel Foot Print by Players
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Deep Dive (Tentative List)
24.2.1. Fertility Nutraceuticals LLC
24.2.1.1. Overview
24.2.1.2. Type Portfolio
24.2.1.3. Profitability by Market Segments (Type/Channel/Region)
24.2.1.4. Sales Footprint
24.2.1.5. Strategy Overview
24.2.1.5.1. Marketing Strategy
24.2.1.5.2. Type Strategy
24.2.2. Exeltis USA, Inc.
24.2.2.1. Overview
24.2.2.2. Type Portfolio
24.2.2.3. Profitability by Market Segments (Type/Channel/Region)
24.2.2.4. Sales Footprint
24.2.2.5. Strategy Overview
24.2.2.5.1. Marketing Strategy
24.2.2.5.2. Type Strategy
24.2.3. TTK HealthCare Ltd.
24.2.3.1. Overview
24.2.3.2. Type Portfolio
24.2.3.3. Profitability by Market Segments (Type/Channel/Region)
24.2.3.4. Sales Footprint
24.2.3.5. Strategy Overview
24.2.3.5.1. Marketing Strategy
24.2.3.5.2. Type Strategy
24.2.4. PregPrep LLC
24.2.4.1. Overview
24.2.4.2. Type Portfolio
24.2.4.3. Profitability by Market Segments (Type/Channel/Region)
24.2.4.4. Sales Footprint
24.2.4.5. Strategy Overview
24.2.4.5.1. Marketing Strategy
24.2.4.5.2. Type Strategy
24.2.5. Orthomol pharmazeutische Vertriebs GmbH
24.2.5.1. Overview
24.2.5.2. Type Portfolio
24.2.5.3. Profitability by Market Segments (Type/Channel/Region)
24.2.5.4. Sales Footprint
24.2.5.5. Strategy Overview
24.2.5.5.1. Marketing Strategy
24.2.5.5.2. Type Strategy
24.2.6. Active Bio Life Science GmbH
24.2.6.1. Overview
24.2.6.2. Type Portfolio
24.2.6.3. Profitability by Market Segments (Type/Channel/Region)
24.2.6.4. Sales Footprint
24.2.6.5. Strategy Overview
24.2.6.5.1. Marketing Strategy
24.2.6.5.2. Type Strategy
24.2.7. Fairhaven Health, LLC
24.2.7.1. Overview
24.2.7.2. Type Portfolio
24.2.7.3. Profitability by Market Segments (Type/Channel/Region)
24.2.7.4. Sales Footprint
24.2.7.5. Strategy Overview
24.2.7.5.1. Marketing Strategy
24.2.7.5.2. Type Strategy
24.2.8. Lenus Pharma GesmbH
24.2.8.1. Overview
24.2.8.2. Type Portfolio
24.2.8.3. Profitability by Market Segments (Type/Channel/Region)
24.2.8.4. Sales Footprint
24.2.8.5. Strategy Overview
24.2.8.5.1. Marketing Strategy
24.2.8.5.2. Type Strategy
24.2.9. ZenithNutrition
24.2.9.1. Overview
24.2.9.2. Type Portfolio
24.2.9.3. Profitability by Market Segments (Type/Channel/Region)
24.2.9.4. Sales Footprint
24.2.9.5. Strategy Overview
24.2.9.5.1. Marketing Strategy
24.2.9.5.2. Type Strategy
24.2.10. INVO Bioscience
24.2.10.1. Overview
24.2.10.2. Type Portfolio
24.2.10.3. Profitability by Market Segments (Type/Channel/Region)
24.2.10.4. Sales Footprint
24.2.10.5. Strategy Overview
24.2.10.5.1. Marketing Strategy
24.2.10.5.2. Type Strategy
24.2.11. Other Players (On Additional Requests)
24.2.11.1. Overview
24.2.11.2. Type Portfolio
24.2.11.3. Profitability by Market Segments (Type/Channel/Region)
24.2.11.4. Sales Footprint
24.2.11.5. Strategy Overview
24.2.11.5.1. Marketing Strategy
24.2.11.5.2. Type Strategy
25. Assumptions and Acronyms Used
26. Research Methodology
Explore Food and Beverage Insights
View Reports
Fertility Supplements Market
